November 17, 2023 | By Amanda Waesch This past September 2023, the Office of Inspector General for the U.S. Department of Health and Human Services (OIG) issued Advisory Opinion 23-06 (AO).1 The Opinion involved a proposed arrangement between an independent pathology laboratory and third-party physician laboratories for the purchase of the technical component of…
April 9, 2021 | By Amanda Waesch In December 2016, Congress passed the 21st Century Cures Act (often simply called the “Cures Act”). Woven within the Cures Act is Section 4004 titled “Information Blocking.”[1] The purpose of this section is to prohibit any action or practice that interferes with or prevents access to electronic…
May 21, 2021 | By Stanley Nachimson, Nachimson Advisors April 5th 2021 was a major day in the history of patient data access. On that day, providers, vendors, and health information networks were required, under federal regulation, to make patient data available electronically to patients. The federal rule, 21st Century Cures Act: Interoperability, Information Blocking,…